Testing effectiveness (Phase 2)Study completedNCT02388048
What this trial is testing
Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia
Who this might be right for
Leukemia, Lymphoblastic, Chronic
Gruppo Italiano Malattie EMatologiche dell'Adulto 19